As an 81-year-old enterprise, we aim to provide our products and services to 20% of the world's population
As an 81-year-old enterprise, we aim to provide our products and services to 20% of the world's population
Was established in
Having a laboratory
Company employees
Master's and PhD ratio
About us
Entai Pharmaceutical
Nanjing Entai Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Entai Pharma”) was established in 2013 and is equipped with internationally advanced instruments and equipment. It is a technology-based enterprise primarily engaged in the discovery, research, and registration of new drugs. The company has recruited high-end talents who have returned from studying abroad as well as experienced professionals from China. Leveraging resources from universities such as China Pharmaceutical University, Nanjing University of Industrial Technology, and Nanjing Medical University, along with abundant government resources, Entai Pharma stays abreast of cutting-edge global R&D trends. By aligning these trends with domestic and international pharmaceutical market demands, the company introduces innovative drugs that are simultaneously launched overseas, ensuring that its research and development efforts maintain a leading edge and high level of innovation within China.
45 patent applications have been filed, and 19 patents have been granted.
Core Technology Platform and Product Pipeline
MAH Holding Platform
Contact the customer proactively within 15 minutes → Through one-on-one communication, clearly identify the type of needs and the core demands.
Generic Drug CRO R&D, Solid Oral Dosage Forms Consistency Evaluation & Injectable Re-evaluation Service Platform
The Joint Business Specialist breaks down the detailed requirements → Within 2 hours, based on service standards and resource availability, they will prepare a preliminary coordination plan.
Chemical Process R&D Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Formulation Technology R&D Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Packaging Material Compatibility R&D Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Metallic Element Impurity Research Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Analytical Testing Service Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Genotoxic Impurity Research Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Regulatory Consulting and Registration Filing Service Platform
Explain the preliminary proposal to the client item by item and answer any questions they may have → Refine the details of the proposal based on the client’s feedback until both parties reach a mutual agreement.
Recommended Products
Using special excipients as carriers and employing encapsulation and pre-filled formulation techniques, we specialize in injectable formulations for encapsulating lipid emulsions and liposome-based molecules. We also develop high-end, complex ophthalmic topical dosage forms—including sustained-release, long-acting, and encapsulated formulations—as well as subcutaneous sustained-release formulations under a pre-filled platform for intra-articular administration.
BLOG
Mar 01,2025
Mar 01,2025
Partner
Forge synergies to develop innovative, unique, novel, and public-benefit-oriented pharmaceutical products that align with contemporary trends, thereby addressing the substantial unmet clinical treatment needs on the front lines of healthcare. We aim to build an internationally competitive, globally-minded pharmaceutical company with a truly global outlook.
Address: 6th Floor, Building C6, Jiangsu Life Science and Technology Innovation Park, Qixia District, Nanjing City
Official account